Efficacy and safety of methylprednisolone pulse therapy for ocular myasthenia gravis: a pilot study
Efficacy and safety of methylprednisolone pulse therapy for ocular myasthenia gravis: a pilot study - ESPRETHO Efficacy and safety of methylprednisolonepulse therapy for ocular myasthenia gravis: a pilot study - ...
Methylprednisolone 1 g daily is administered intravenously for 3 consecutive days for 2 to 3 courses, and then 5 mg of prednisolone daily is orally administered until 16 weeks. Methylprednisolone1 g daily is administered intravenously for 3 consecutive days for 2 to 3 courses, ...
A Study to Investigate the Safety, Tolerability, and Efficacy of TAK-079 in Participants With Generalized Myasthenia Gravis A Study to Investigate the Safety, Tolerability, and Efficacy of TAK-079 in Participants With Genera ...
A Phase 2, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of TAK-079 in Patients With Generalized Myasthenia Gravis - - A Phase 2, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of TA ...